Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sensors (Basel) ; 22(5)2022 Mar 05.
Article in English | MEDLINE | ID: mdl-35271187

ABSTRACT

One of the development directions of new-generation mobile communications is using multiple-input multiple-output (MIMO) channels with a large number of antennas. This requires the development and utilization of new approaches to signal detection in MIMO channels, since the difference in the energy efficiency and the complexity between the optimal maximum likelihood algorithm and simpler linear algorithms become very large. The goal of the presented study is the development of a method for transforming a MIMO channel into a model based on a sparse matrix with a limited number of non-zero elements in a row. It was shown that the MIMO channel can be represented in the form of a Markov process. Hence, it becomes possible to use simple iterative MIMO demodulation algorithms such as message-passing algorithms (MPAs) and Turbo.


Subject(s)
Algorithms
2.
J Pharmacol Exp Ther ; 318(2): 579-88, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16709679

ABSTRACT

Previously, we have described the modulatory effect of diadenosine polyphosphates Ap4A and Ap5A on synaptic transmission in the rat hippocampal slices mediated by presynaptic receptors (Klishin et al., 1994). In contrast, we now describe how nonhydrolyzable Ap4A analog diadenosine-5',5'''-P1,P4-[beta,beta'-methylene]tetraphosphate (AppCH2ppA) at low micromolar concentrations exerts strong nondesensitizing inhibition of orthodromically evoked field potentials (OFPs) without affecting the amplitude of excitatory postsynaptic currents and antidromically evoked field potentials, as recorded in hippocampal CA1 zone. The effects of AppCH2ppA on OFPs are eliminated by a P2 receptor antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid (PPADS) but not mimicked by purinoceptor agonists alpha,beta-methylene-ATP and adenosine 5'-O-(3-thio)-triphosphate, indicating that a P2-like receptor is involved but not one belonging to the conventional P2X/P2Y receptor classes. Diadenosine polyphosphate receptor (P4) antagonist Ip4I (diinosine tetraphosphate) was unable to modulate AppCH2ppA effects. Thus, the PPADS-sensitive P2-like receptor for AppCH2ppA seems to control selectively dendritic excitation of the CA1 neurons. The specific nitric oxide (NO)-scavenger 2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide is shown to significantly attenuate AppCH2ppA-mediated inhibitory effects, indicating that NO is involved in the cascade of events initiated by AppCH2ppA. Further downstream mediation by adenosine A1 receptors is also demonstrated. Hence, AppCH2ppA-mediated effects involve PPADS-sensitive P2-like receptor activation leading to the production of NO that stimulates intracellular synthesis of adenosine, causing in turn postsynaptic A1 receptor activation and subsequent postsynaptic CA1 dendritic inhibition. Such spatially selective postsynaptic dendritic inhibition may influence dendritic electrogenesis in pyramidal neurons and consequently mediate control of neuronal network activity.


Subject(s)
Dinucleoside Phosphates/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Nitric Oxide/physiology , Adenosine/pharmacology , Animals , Cyclic N-Oxides/pharmacology , Dendrites/drug effects , Electric Stimulation , Electrophysiology , Hippocampus/cytology , Hippocampus/drug effects , Hydrolysis , Imidazoles/pharmacology , Nitroglycerin/pharmacology , Patch-Clamp Techniques , Purinergic Agonists , Purinergic Antagonists , Pyramidal Cells/drug effects , Pyridoxal Phosphate/analogs & derivatives , Pyridoxal Phosphate/pharmacology , Rats , Rats, Wistar , Synaptic Transmission/drug effects
3.
Brain Res ; 1011(2): 195-205, 2004 Jun 18.
Article in English | MEDLINE | ID: mdl-15157806

ABSTRACT

Numerous data indicate that nonsynaptic release of glutamate occurs both in normal and pathophysiological conditions. When reaching receptors in the postsynaptic density (PSD), glutamate (Glu) could affect the synaptic transmission. We have tested this possibility in the hippocampal CA1 synapses of rats, either by applying exogenous Glu to the CA1 neurons or by disruption of Glu transporter activity. L-Glu (400 microM) was directly applied to the hippocampal slices acutely isolated from the rats. It produced a strong inhibition of both ortho- and antidromically elicited action potentials fired by CA1 neurons while the excitatory postsynaptic current (EPSC) measured in these neurons remained totally unaffected. The optical isomer D-Glu which is not transported by the systems of Glu uptake inhibited not only orthodromic and antidromic spikes, but also EPSC. Non-specific glutamate transporter inhibitor DL-threo-beta-hydroxyaspartic acid (THA, 400 microM) mimicked the effects of exogenous Glu and produced strong inhibition of both orthodromic and antidromic spikes, without any influence on the amplitude of EPSCs. Dihydrokainate (DHK, 300 microM), selective inhibitor of GLT-1 subtype of glutamate transporter, exerted a significant inhibitory action on the orthodromically evoked spikes and also on the EPSC. Our results indicate that extrasynaptic and PSD membranes of CA1 neurons form separate compartments differing in the mechanisms and efficiency of external Glu processing: the protection of PSD markedly prevails.


Subject(s)
Glutamic Acid/pharmacology , Hippocampus/cytology , Kainic Acid/analogs & derivatives , Synapses/drug effects , Synapses/physiology , 4-Aminopyridine/pharmacology , Amino Acid Transport System X-AG/antagonists & inhibitors , Animals , Animals, Newborn , Aspartic Acid/analogs & derivatives , Aspartic Acid/pharmacology , Dizocilpine Maleate/pharmacology , Drug Interactions , Evoked Potentials/physiology , Evoked Potentials/radiation effects , Excitatory Amino Acid Agonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Postsynaptic Potentials/drug effects , In Vitro Techniques , Kainic Acid/pharmacology , Models, Neurological , N-Methylaspartate/pharmacology , Neural Inhibition/drug effects , Neurons/drug effects , Potassium Channel Blockers/pharmacology , Quinoxalines/pharmacology , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...